a controlled clinical trial of rifaprim ( rifampicin 600 mg plus trimethoprim 160 mg , in a single daily dose at 10 p.m. ) and cotrimoxazole ( two tablets b.i.d . ) was carried out in two groups of twenty-one patients , each with chronic or recurrent urinary tract infections .
C0041041
trimethoprim
C0041044
cotrimoxazole